198 related articles for article (PubMed ID: 36271425)
21. Biomarkers of inflammation in major vascular surgery: a prospective randomised trial.
Lindholm EE; Aune E; Seljeflot I; Otterstad JE; Kirkebøen KA
Acta Anaesthesiol Scand; 2015 Jul; 59(6):773-87. PubMed ID: 25626738
[TBL] [Abstract][Full Text] [Related]
22. Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation studies based on the CIMESTRA and OPERA trials.
Brahe CH; Dehlendorff C; Østergaard M; Johansen JS; Ørnbjerg LM; Hørslev-Petersen K; Stengaard-Pedersen K; Junker P; Ellingsen T; Lindegaard H; Hansen I; Lottenburger T; Jacobsen S; Jurik AG; Hetland ML
Scand J Rheumatol; 2018 Jul; 47(4):259-269. PubMed ID: 29336711
[TBL] [Abstract][Full Text] [Related]
23. Postoperative serum CA19-9, YKL-40, CRP and IL-6 in combination with CEA as prognostic markers for recurrence and survival in colorectal cancer.
Hermunen K; Soveri LM; Boisen MK; Mustonen HK; Dehlendorff C; Haglund CH; Johansen JS; Osterlund P
Acta Oncol; 2020 Dec; 59(12):1416-1423. PubMed ID: 32790589
[TBL] [Abstract][Full Text] [Related]
24. Increased Obesity-Associated Circulating Levels of the Extracellular Matrix Proteins Osteopontin, Chitinase-3 Like-1 and Tenascin C Are Associated with Colon Cancer.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Izaguirre M; Hernández-Lizoain JL; Baixauli J; Martí P; Valentí V; Moncada R; Silva C; Salvador J; Frühbeck G
PLoS One; 2016; 11(9):e0162189. PubMed ID: 27612200
[TBL] [Abstract][Full Text] [Related]
25. Relationships between increased circulating YKL-40, IL-6 and TNF-α levels and phenotypes and disease activity of primary Sjögren's syndrome.
Chen C; Liang Y; Zhang Z; Zhang Z; Yang Z
Int Immunopharmacol; 2020 Nov; 88():106878. PubMed ID: 32791244
[TBL] [Abstract][Full Text] [Related]
26. ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitors.
Pedersen SJ; Sørensen IJ; Garnero P; Johansen JS; Madsen OR; Tvede N; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen K; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Skjødt T; Lambert R; Hansen A; Østergaard M
Ann Rheum Dis; 2011 Aug; 70(8):1375-81. PubMed ID: 21551511
[TBL] [Abstract][Full Text] [Related]
27. Analysis of YKL-40 acute-phase protein and interleukin-6 levels in periodontal disease.
Keles ZP; Keles GC; Avci B; Cetinkaya BO; Emingil G
J Periodontol; 2014 Sep; 85(9):1240-6. PubMed ID: 24635545
[TBL] [Abstract][Full Text] [Related]
28. Specific biomarkers of myocardial inflammation and remodeling processes as predictors of mortality in high-risk patients undergoing percutaneous mitral valve repair (MitraClip).
Dörr O; Walther C; Liebetrau C; Keller T; Tabert H; Boeder N; Bayer M; Bauer P; Möllmann H; Gaede L; Troidl C; Voss S; Bauer T; Hamm CW; Nef H
Clin Cardiol; 2018 Apr; 41(4):481-487. PubMed ID: 29663512
[TBL] [Abstract][Full Text] [Related]
29. Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.
Biggar RJ; Johansen JS; Smedby KE; Rostgaard K; Chang ET; Adami HO; Glimelius B; Molin D; Hamilton-Dutoit S; Melbye M; Hjalgrim H
Clin Cancer Res; 2008 Nov; 14(21):6974-8. PubMed ID: 18980992
[TBL] [Abstract][Full Text] [Related]
30. YKL-40 as a novel factor associated with inflammation and catabolic mechanisms in osteoarthritic joints.
Väänänen T; Koskinen A; Paukkeri EL; Hämäläinen M; Moilanen T; Moilanen E; Vuolteenaho K
Mediators Inflamm; 2014; 2014():215140. PubMed ID: 25132728
[TBL] [Abstract][Full Text] [Related]
31. YKL-40, a novel marker of cardiovascular complications, is related to kidney function in heart transplant recipients.
Przybyłowski P; Janik L; Wasilewski G; Nowak E; Koźlik P; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2860-3. PubMed ID: 25380936
[TBL] [Abstract][Full Text] [Related]
32. YKL-40 is elevated in morbidly obese patients and declines after weight loss.
Hempen M; Kopp HP; Elhenicky M; Höbaus C; Brix JM; Koppensteiner R; Schernthaner G; Schernthaner GH
Obes Surg; 2009 Nov; 19(11):1557-63. PubMed ID: 19633900
[TBL] [Abstract][Full Text] [Related]
33. Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnover.
Pedersen SJ; Sørensen IJ; Lambert RG; Hermann KG; Garnero P; Johansen JS; Madsen OR; Hansen A; Hansen MS; Thamsborg G; Andersen LS; Majgaard O; Loft AG; Erlendsson J; Asmussen KH; Jurik AG; Møller J; Hasselquist M; Mikkelsen D; Østergaard M
Arthritis Rheum; 2011 Dec; 63(12):3789-800. PubMed ID: 22127697
[TBL] [Abstract][Full Text] [Related]
34. YKL-40, a marker of cardiovascular disease and endothelial dysfunction, in kidney transplant recipients.
Malyszko J; Koc-Zorawska E; Malyszko J
Transplant Proc; 2014 Oct; 46(8):2651-3. PubMed ID: 25380887
[TBL] [Abstract][Full Text] [Related]
35. Chitinase-like protein YKL-40 correlates with inflammatory phenotypes, anti-asthma responsiveness and future exacerbations.
Liu L; Zhang X; Liu Y; Zhang L; Zheng J; Wang J; Hansbro PM; Wang L; Wang G; Hsu AC
Respir Res; 2019 May; 20(1):95. PubMed ID: 31113430
[TBL] [Abstract][Full Text] [Related]
36. Progressive increase of matrix metalloprotease-9 and interleukin-8 serum levels during carcinogenic process in human colorectal tract.
Biasi F; Guina T; Maina M; Nano M; Falcone A; Aroasio E; Saracco GM; Papotti M; Leonarduzzi G; Poli G
PLoS One; 2012; 7(7):e41839. PubMed ID: 22848630
[TBL] [Abstract][Full Text] [Related]
37. Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects.
Väänänen T; Lehtimäki L; Vuolteenaho K; Hämäläinen M; Oksa P; Vierikko T; Järvenpää R; Uitti J; Kankaanranta H; Moilanen E
Mediators Inflamm; 2017; 2017():1797512. PubMed ID: 28588347
[TBL] [Abstract][Full Text] [Related]
38. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC
Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer.
Chen IM; Johansen AZ; Dehlendorff C; Jensen BV; Bojesen SE; Pfeiffer P; Bjerregaard JK; Nielsen SE; Andersen F; Holländer NH; Yilmaz MK; Rasmussen LS; Johansen JS
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):176-184. PubMed ID: 31685562
[TBL] [Abstract][Full Text] [Related]
40. Analysis of the acute systemic and tissue inflammatory response following carotid endarterectomy.
Gabrile SA; Antonangelo L; Capelozzi VR; Beteli CB; DE Camargo O; Braga DE Aquino JL; Caffaro RA
Int Angiol; 2016 Apr; 35(2):148-56. PubMed ID: 25994448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
